• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: WILLIAM A. COOK AUSTRALIA, PTY LTD ZENITH FENESTRATED AAA ENDOVASCULAR GRAFT PROXIMAL BODY; MIH SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

WILLIAM A. COOK AUSTRALIA, PTY LTD ZENITH FENESTRATED AAA ENDOVASCULAR GRAFT PROXIMAL BODY; MIH SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number G32537
Device Problems Mechanical Jam (2983); Physical Resistance/Sticking (4012)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 06/12/2023
Event Type  malfunction  
Event Description
Upon deployment and attempted removal of the black trigger wire, the trigger wire would not release from the top cap and the graft was being pulled down and crunched in an accordion-like manner.Repeated attempt to deploy were unsuccessful.Manual deployment was completed (with white trigger wire) with use of kelly clamps to release the bottom of graft followed by manual deployment of the black trigger wire and deployment of the suprarenal top cap.The graft was able to be reformed but not entirely.The procedure was completed successfully.
 
Event Description
Upon deployment and attempted removal of the black trigger wire, the trigger wire would not release from the top cap and the graft was being pulled down and crunched in an accordion-like manner.Repeated attempt to deploy were unsuccessful.Manual deployment was completed (with white trigger wire) with use of kelly clamps to release the bottom of graft followed by manual deployment of the black trigger wire and deployment of the suprarenal top cap.The graft was able to be reformed but not entirely.The procedure was completed successfully.
 
Manufacturer Narrative
No part of the device was returned for evaluation.Additional information was requested, but no further information was received.No imaging was received to assist the investigation.During a review of manufacturing records, the work order appeared complete, and the quality control inspection was verified to ensure that the device passed inspection.There were no non-conformance's raised or temporary deviations in place at the time of manufacture.A review of specifications did not reveal any discrepancies that could have contributed to this occurrence and found that there are a number of processes and checks in place which would likely identify a device deficiency prior to shipment.Review of the instructions for use (ifu) supplied with the device found that it contained appropriate warnings, precautions, and instructions to the user, including: 4.3 implant procedure ¿ maintain wire guide position during delivery system insertion.¿ fluoroscopy should be used during introduction and deployment to confirm proper operation of the delivery system components, proper placement of the graft, and desired procedural outcome.¿ to avoid any twist in the endovascular graft, during any rotation of the delivery system, be careful to rotate all of the components of the system together (from outer sheath to inner cannula).¿ do not continue advancing any portion of the delivery system if resistance is felt during advancement of the wire guide or delivery system.Stop and assess the cause of resistance.Vessel or catheter damage may occur.Exercise particular care in areas of stenosis, intravascular thrombosis or in calcified or tortuous vessels.¿ take care during manipulation of catheters, wires and sheaths within an aneurysm.Significant disturbances may dislodge fragments of thrombus, which can cause distal embolization.There is no evidence to suggest that the user did not follow the instructions for use.A definitive root cause could not be determined from the investigation.Possible root cause(s) are: ¿ inadequate material selection ¿ wire entanglement within the system ¿ wire jammed within top cap ¿ high friction interaction with adjacent materials ¿ tortuosity in trigger wire path within the delivery system ¿ patient/procedural factors.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ZENITH FENESTRATED AAA ENDOVASCULAR GRAFT PROXIMAL BODY
Type of Device
MIH SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
WILLIAM A. COOK AUSTRALIA, PTY LTD
95 brandl street
eight mile plains
brisbane
AS 
Manufacturer (Section G)
WILLIAM A. COOK AUSTRALIA, PTY LTD
95 brandl street
eight mile plains
brisbane
AS  
Manufacturer Contact
tia gibb
95 brandl street
eight mile plains
brisbane 
AS  
MDR Report Key17132116
MDR Text Key317489278
Report Number9680654-2023-00039
Device Sequence Number1
Product Code MIH
UDI-Device Identifier10827002325378
UDI-Public(01)10827002325378(17)260509(10)AC1133582
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P020018
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 08/08/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberG32537
Device Catalogue NumberZFEN-P-2-28-109-R
Device Lot NumberAC1133582
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/13/2023
Initial Date FDA Received06/14/2023
Supplement Dates Manufacturer Received06/13/2023
Supplement Dates FDA Received08/07/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/09/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age69 YR
Patient SexMale
-
-